The Cost-Effectiveness of Exenatide Bid Versus Insulin Lispro Tid As Add-On Therapy to Titrated Insulin Glargine in Patients With Type 2 Diabetes – An Analysis From The Swedish Health Care Perspective

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.693
https://www.valueinhealthjournal.com/article/S1098-3015(14)02623-0/fulltext
Title : The Cost-Effectiveness of Exenatide Bid Versus Insulin Lispro Tid As Add-On Therapy to Titrated Insulin Glargine in Patients With Type 2 Diabetes – An Analysis From The Swedish Health Care Perspective
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02623-0&doi=10.1016/j.jval.2014.08.693
First page : A344
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 115
Categories :
Tags :
Regions :
ViH Article Tags :